| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Bayesian basket trial design using a calibrated Bayesian hierarchical model
|
Chu, Yiyi
|
|
2018
|
|
2 |
p. 149-158
|
artikel
|
| 2 |
A Bayesian dose-finding trial with adaptive dose expansion to flexibly assess efficacy and safety of an investigational drug
|
Berry, Scott M
|
|
2010
|
|
2 |
p. 121-135
|
artikel
|
| 3 |
A Bayesian meta-analytic approach for safety signal detection in randomized clinical trials
|
Odani, Motoi
|
|
2017
|
|
2 |
p. 192-200
|
artikel
|
| 4 |
Abstracts
|
|
|
2004
|
|
2 |
p. 209-258
|
artikel
|
| 5 |
Abstracts from the Society for Clinical Trials Annual Meeting, Boston, Massachusetts, USA - May 19-22, 2013
|
|
|
2013
|
|
2 |
p. S1-S88
|
artikel
|
| 6 |
Academic chartered data safety committees versus industry sponsored data safety committees: The need for different recommendations
|
Weber, David J
|
|
2018
|
|
2 |
p. 212-213
|
artikel
|
| 7 |
A community consultation survey to evaluate support for and success of the IMMEDIATE trial
|
Beshansky, Joni R
|
|
2014
|
|
2 |
p. 178-186
|
artikel
|
| 8 |
A comparison of confidence interval methods for the intraclass correlation coefficient in community-based cluster randomization trials with a binary outcome
|
Braschel, Melissa C
|
|
2016
|
|
2 |
p. 180-187
|
artikel
|
| 9 |
Adaptive dose insertion in early phase clinical trials
|
Hu, Bo
|
|
2013
|
|
2 |
p. 216-224
|
artikel
|
| 10 |
Adaptive parametric prediction of event times in clinical trials
|
Lan, Yu
|
|
2018
|
|
2 |
p. 159-168
|
artikel
|
| 11 |
A decision rule for sequential monitoring of clinical trials with a primary and supportive outcome
|
Zhao, Yanli
|
|
2007
|
|
2 |
p. 140-153
|
artikel
|
| 12 |
Adherence reporting in randomized controlled trials
|
Zhang, Ze
|
|
2014
|
|
2 |
p. 195-204
|
artikel
|
| 13 |
Alignment of site versus adjudication committee–based diagnosis with patient outcomes: Insights from the Providing Rapid Out of Hospital Acute Cardiovascular Treatment 3 trial
|
Sepehrvand, Nariman
|
|
2016
|
|
2 |
p. 140-148
|
artikel
|
| 14 |
A model for the design and implementation of a participant recruitment registry for clinical studies of older adults
|
Dowling, N Maritza
|
|
2012
|
|
2 |
p. 204-214
|
artikel
|
| 15 |
Analysis of combined data from heterogeneous study designs: an applied example from the patient navigation research program
|
Roetzheim, Richard G
|
|
2012
|
|
2 |
p. 176-187
|
artikel
|
| 16 |
An analysis of adaptive design variations on the sequential parallel comparison design for clinical trials
|
Mi, Michael Y
|
|
2013
|
|
2 |
p. 207-215
|
artikel
|
| 17 |
An approach to combining parallel and cross-over trials with and without run-in periods using individual patient data
|
Tvete, Ingunn F
|
|
2012
|
|
2 |
p. 164-175
|
artikel
|
| 18 |
An embedded randomised controlled trial of a Teaser Campaign to optimise recruitment in primary care
|
Lee, Hopin
|
|
2017
|
|
2 |
p. 162-169
|
artikel
|
| 19 |
An evaluation of the effectiveness of recruitment methods: The staying well after depression randomized controlled trial
|
Krusche, Adele
|
|
2014
|
|
2 |
p. 141-149
|
artikel
|
| 20 |
An Institutional Review Board dilemma: responsible for safety monitoring but not in control
|
DeMets, David L
|
|
2006
|
|
2 |
p. 142-148
|
artikel
|
| 21 |
A note on masking in the SOX trial
|
Berger, Vance W
|
|
2015
|
|
2 |
p. 177-177
|
artikel
|
| 22 |
A point-of-care clinical trial comparing insulin administered using a sliding scale versus a weight-based regimen
|
Fiore, Louis D
|
|
2011
|
|
2 |
p. 183-195
|
artikel
|
| 23 |
Apparent relationship between relative risk and control rate: statistical artifact or selection bias?
|
Weisberg, Herbert I
|
|
2010
|
|
2 |
p. 118-119
|
artikel
|
| 24 |
A practical look at cluster-randomized trials
|
Moulton, Lawrence H
|
|
2005
|
|
2 |
p. 89-90
|
artikel
|
| 25 |
A predictive probability design for phase II cancer clinical trials
|
Lee, J Jack
|
|
2008
|
|
2 |
p. 93-106
|
artikel
|
| 26 |
A randomized recruitment intervention trial in Parkinson’s disease to increase participant diversity: early stopping for lack of efficacy
|
Tilley, Barbara C
|
|
2012
|
|
2 |
p. 188-197
|
artikel
|
| 27 |
Architecture design of a generic centralized adjudication module integrated in a web-based clinical trial management system
|
Zhao, Wenle
|
|
2016
|
|
2 |
p. 223-233
|
artikel
|
| 28 |
Are outcome-adaptive allocation trials ethical?
|
Hey, Spencer Phillips
|
|
2015
|
|
2 |
p. 102-106
|
artikel
|
| 29 |
Are pilot trials useful for predicting randomisation and attrition rates in definitive studies: A review of publicly funded trials
|
Cooper, Cindy L
|
|
2018
|
|
2 |
p. 189-196
|
artikel
|
| 30 |
A review of the impact of utilising electronic medical records for clinical research recruitment
|
Lai, Yan See
|
|
|
|
2 |
p. 194-203
|
artikel
|
| 31 |
Assessing the impact of efficacy stopping rules on the error rates under the multi-arm multi-stage framework
|
Blenkinsop, Alexandra
|
|
|
|
2 |
p. 132-141
|
artikel
|
| 32 |
Automated measurements for individualized heart rate correction of the QT interval
|
Mason, Jay W
|
|
2015
|
|
2 |
p. 149-155
|
artikel
|
| 33 |
Avoiding bias and incorrect confidence interval coverage in prescription drug labeling
|
Levin, Gregory
|
|
2016
|
|
2 |
p. 199-204
|
artikel
|
| 34 |
A web-based clinical trial management system for a sham-controlled multicenter clinical trial in depression
|
Durkalski, Valerie
|
|
2010
|
|
2 |
p. 174-182
|
artikel
|
| 35 |
Barriers and facilitators to clinical trial participation among parents of children with pediatric neuromuscular disorders
|
Peay, Holly L
|
|
2018
|
|
2 |
p. 139-148
|
artikel
|
| 36 |
Barriers and opportunities for implementation of adaptive designs in pharmaceutical product development
|
Quinlan, Judith
|
|
2010
|
|
2 |
p. 167-173
|
artikel
|
| 37 |
Bayesian models for subgroup analysis in clinical trials
|
Jones, Hayley E
|
|
2011
|
|
2 |
p. 129-143
|
artikel
|
| 38 |
Benchmarks for designing two-stage studies using modified mini-mental state examinations: experience from the Women's Health Initiative Memory Study
|
Espeland, Mark A
|
|
2006
|
|
2 |
p. 99-106
|
artikel
|
| 39 |
Benefits and barriers to participating in longitudinal research of youth-onset type 2 diabetes: Results from the TODAY retention survey
|
Walders-Abramson, Natalie
|
|
2016
|
|
2 |
p. 240-243
|
artikel
|
| 40 |
Book Review: Design and analysis of clinical trials
|
Brannath, W
|
|
2006
|
|
2 |
p. 158-159
|
artikel
|
| 41 |
BookReview: Green S, Benedetti J and Crowley J 2003: Clinical trials in oncology. Second edition. Boca Raton: Chapman & Hall/CRC. 265 pp. US $79.95 (US $71.96 web price) (HB). ISBN 1 58488 302 2
|
Lombard, C.J.
|
|
2004
|
|
2 |
p. 185-186
|
artikel
|
| 42 |
BookReview: Jerry Menikoff and Edward P. Richards 2006: What the Doctor Didn't Say: The Hidden Truth about Medical Research. Oxford University Press. $34.99. ISBN-13 978-0-19-514797-1
|
Dixon, Dennis
|
|
2009
|
|
2 |
p. 196-197
|
artikel
|
| 43 |
Book Review: JM Gueron and H Rolston 2013: Fighting for reliable
|
Wittes, Janet Turk
|
|
2014
|
|
2 |
p. 267-269
|
artikel
|
| 44 |
Building community partnerships: case studies of Community Advisory Boards at research sites in Peru, Zimbabwe, and Thailand
|
Morin, Stephen F
|
|
2008
|
|
2 |
p. 147-156
|
artikel
|
| 45 |
Building trust and diversity in patient-centered oncology clinical trials: An integrated model
|
Hurd, Thelma C
|
|
2017
|
|
2 |
p. 170-179
|
artikel
|
| 46 |
Caregiver-assisted coping skills training for patients with COPD: background, design, and methodological issues for the INSPIRE-II study
|
Blumenthal, James A
|
|
2009
|
|
2 |
p. 172-184
|
artikel
|
| 47 |
Central site monitoring: Results from a test of accuracy in identifying trials and sites failing Food and Drug Administration inspection
|
Lindblad, Anne S
|
|
2014
|
|
2 |
p. 205-217
|
artikel
|
| 48 |
Central statistical monitoring: Detecting fraud in clinical trials
|
Pogue, Janice M
|
|
2013
|
|
2 |
p. 225-235
|
artikel
|
| 49 |
Challenges and solutions in the design and execution of the PROSPECT Phase II/III neoadjuvant rectal cancer trial (NCCTG N1048/Alliance)
|
Schrag, Deborah
|
|
|
|
2 |
p. 165-175
|
artikel
|
| 50 |
Challenges in the design and conduct of controlled clinical effectiveness trials in schizophrenia
|
Rosenheck, Robert A
|
|
2011
|
|
2 |
p. 196-204
|
artikel
|
| 51 |
Challenges in the research ethics review of cluster randomized trials: International survey of investigators
|
Chaudhry, Shazia H
|
|
2013
|
|
2 |
p. 257-268
|
artikel
|
| 52 |
Clinical trial designs for testing biomarker-based personalized therapies
|
Lai, Tze Leung
|
|
2012
|
|
2 |
p. 141-154
|
artikel
|
| 53 |
Clinician-trialist rounds: 9. Mentoring – part 3: the structure and function of effective mentoring: advice and protection
|
Straus, Sharon E
|
|
2012
|
|
2 |
p. 272-274
|
artikel
|
| 54 |
Clinician-trialist rounds: 3. Priority setting for academic success
|
Sackett, David L
|
|
2011
|
|
2 |
p. 235-237
|
artikel
|
| 55 |
Clinician-trialist rounds: 26. Sabbaticals. Part 1: Should I take a sabbatical?
|
Straus, Sharon E
|
|
2015
|
|
2 |
p. 174-176
|
artikel
|
| 56 |
Clinician-trialist rounds: 20. Shouldn’t ‘trialists-in-training’ rotate through RCT-clerkships?
|
Sackett, David L
|
|
2014
|
|
2 |
p. 263-266
|
artikel
|
| 57 |
Clinician-trialist rounds: 15. Ways to advance your career by saying ‘no’ – part 3: how to say ‘no’, nicely
|
Oxman, Andrew D
|
|
2013
|
|
2 |
p. 340-343
|
artikel
|
| 58 |
Commentary on Fleming et al.: Data monitoring committee evidence base needed
|
Terrin, Michael
|
|
2017
|
|
2 |
p. 124-125
|
artikel
|
| 59 |
Commentary on Hey and Kimmelman
|
Joffe, Steven
|
|
2015
|
|
2 |
p. 116-118
|
artikel
|
| 60 |
Commentary on Hey and Kimmelman
|
Korn, Edward L
|
|
2015
|
|
2 |
p. 122-124
|
artikel
|
| 61 |
Commentary on Hey and Kimmelman
|
Lee, J Jack
|
|
2015
|
|
2 |
p. 110-112
|
artikel
|
| 62 |
Commentary on Hey and Kimmelman
|
Buyse, Marc
|
|
2015
|
|
2 |
p. 119-121
|
artikel
|
| 63 |
Commentary on Hey and Kimmelman
|
Berry, Donald A
|
|
2015
|
|
2 |
p. 107-109
|
artikel
|
| 64 |
Commentary on Hey and Kimmelman
|
Saxman, Scott Brian
|
|
2015
|
|
2 |
p. 113-115
|
artikel
|
| 65 |
Commentary on Sertkaya et al. and Larson et al.
|
Eisenstein, Eric L
|
|
2016
|
|
2 |
p. 137-139
|
artikel
|
| 66 |
Comment on Vickers et al.
|
Chappell, Rick
|
|
|
|
2 |
p. 214-215
|
artikel
|
| 67 |
Comparison of characteristics and outcomes by initial study contact (website versus staff) for participants enrolled in a weight management study
|
Funk, Kristine L
|
|
2012
|
|
2 |
p. 226-231
|
artikel
|
| 68 |
Conditional estimation and inference to address observed covariate imbalance in randomized clinical trials
|
Zhang, Zhiwei
|
|
|
|
2 |
p. 122-131
|
artikel
|
| 69 |
Conducting clinical trials—costs, impacts, and the value of clinical trials networks: A scoping review
|
Bentley, Colene
|
|
|
|
2 |
p. 183-193
|
artikel
|
| 70 |
Corrigendum
|
|
|
2017
|
|
2 |
p. 222
|
artikel
|
| 71 |
Corrigendum
|
|
|
|
|
2 |
p. 219
|
artikel
|
| 72 |
Corrigendum
|
|
|
2009
|
|
2 |
p. 198-198
|
artikel
|
| 73 |
Cost-effectiveness in clinical trials: using multiple imputation to deal with incomplete cost data
|
Burton, Andrea
|
|
2007
|
|
2 |
p. 154-161
|
artikel
|
| 74 |
Cost-efficient designs for three-arm trials with treatment delivered by health professionals: Sample sizes for a combination of nested and crossed designs
|
Moerbeek, Mirjam
|
|
2018
|
|
2 |
p. 169-177
|
artikel
|
| 75 |
Data and safety monitoring in social behavioral intervention trials: the REACH II experience
|
Czaja, Sara J
|
|
2006
|
|
2 |
p. 107-118
|
artikel
|
| 76 |
Data monitoring committees: Promoting best practices to address emerging challenges
|
Fleming, Thomas R
|
|
2017
|
|
2 |
p. 115-123
|
artikel
|
| 77 |
Delivering successful randomized controlled trials in surgery: Methods to optimize collaboration and study design
|
Blencowe, Natalie S
|
|
2017
|
|
2 |
p. 211-218
|
artikel
|
| 78 |
Design and analysis of clinical trials with clustering effects due to treatment
|
Roberts, Chris
|
|
2005
|
|
2 |
p. 152-162
|
artikel
|
| 79 |
Design and sample size considerations for Alzheimer’s disease prevention trials using multistate models
|
Brookmeyer, Ron
|
|
|
|
2 |
p. 111-119
|
artikel
|
| 80 |
Design of the Value of Imaging in Enhancing the Wellness of Your Heart (VIEW) trial and the impact of uncertainty on power
|
Ambrosius, Walter T
|
|
2012
|
|
2 |
p. 232-246
|
artikel
|
| 81 |
Determinants of the intracluster correlation coefficient in cluster randomized trials: the case of implementation research
|
Campbell, Marion K
|
|
2005
|
|
2 |
p. 99-107
|
artikel
|
| 82 |
Developing targeted therapy
|
Siegel, Jay P.
|
|
2007
|
|
2 |
p. 170-172
|
artikel
|
| 83 |
Development of a checklist of quality indicators for clinical trials in resource-limited countries: The French National Agency for Research on AIDS and Viral Hepatitis (ANRS) experience
|
Hanna, Mina
|
|
2013
|
|
2 |
p. 300-318
|
artikel
|
| 84 |
Development of adherence metrics for caloric restriction interventions
|
Pieper, Carl
|
|
2011
|
|
2 |
p. 155-164
|
artikel
|
| 85 |
Differential recruitment in a cluster randomized trial in primary care: the experience of the UK Back pain, Exercise, Active management and Manipulation (UK BEAM) feasibility study
|
Farrin, Amanda
|
|
2005
|
|
2 |
p. 119-124
|
artikel
|
| 86 |
Discussion
|
Norton, Larry
|
|
2007
|
|
2 |
p. 173-175
|
artikel
|
| 87 |
Discussion
|
Ellenberg, Susan S.
|
|
2007
|
|
2 |
p. 176-177
|
artikel
|
| 88 |
Do antidepressants cause suicidality in children? A Bayesian meta-analysis
|
Kaizar, Eloise E
|
|
2006
|
|
2 |
p. 73-98
|
artikel
|
| 89 |
Does treatment effect depend on control event rate? Revisiting a meta-analysis of suicidality and antidepressant use in children
|
Proschan, Michael A
|
|
2010
|
|
2 |
p. 109-117
|
artikel
|
| 90 |
Editorial: We may need large trials to find treatments for neurodegenerative diseases
|
Schoenfeld, David Alan
|
|
|
|
2 |
p. 120-121
|
artikel
|
| 91 |
Effectiveness of strategies to recruit underrepresented populations into cancer clinical trials
|
Lai, Gabriel Y
|
|
2006
|
|
2 |
p. 133-141
|
artikel
|
| 92 |
Efficacy and cost-effectiveness of an automated screening algorithm in an inpatient clinical trial
|
Beauharnais, Catherine C
|
|
2012
|
|
2 |
p. 198-203
|
artikel
|
| 93 |
E-health data to support and enhance randomised controlled trials in the United Kingdom
|
Harron, Katie
|
|
2015
|
|
2 |
p. 180-182
|
artikel
|
| 94 |
Eliciting and using expert opinions about dropout bias in randomized controlled trials
|
White, Ian R
|
|
2007
|
|
2 |
p. 125-139
|
artikel
|
| 95 |
Enrollment of racially/ethnically diverse participants in traumatic brain injury trials: Effect of availability of exception from informed consent
|
Yamal, Jose-Miguel
|
|
2014
|
|
2 |
p. 187-194
|
artikel
|
| 96 |
Equipoise: a case study of the views of clinicians involved in two neonatal trials
|
Garcia, Jo
|
|
2004
|
|
2 |
p. 170-178
|
artikel
|
| 97 |
Erratum
|
|
|
2005
|
|
2 |
p. 194-194
|
artikel
|
| 98 |
Ethical concerns about adaptive randomization
|
Begg, Colin B
|
|
2015
|
|
2 |
p. 101-101
|
artikel
|
| 99 |
Ethical issues in HIV prevention research with people who inject drugs
|
Sugarman, Jeremy
|
|
2014
|
|
2 |
p. 239-245
|
artikel
|
| 100 |
Evaluating the safety of a rotavirus vaccine: the REST of the story
|
Heyse, Joseph F
|
|
2008
|
|
2 |
p. 131-139
|
artikel
|
| 101 |
Fallacies of last observation carried forward analyses
|
Lachin, John M
|
|
2016
|
|
2 |
p. 161-168
|
artikel
|
| 102 |
Food and Drug Administration guidance on progression-free survival and the intention-to-treat principle
|
Dixon, Dennis
|
|
2015
|
|
2 |
p. 179-179
|
artikel
|
| 103 |
From ClinicalTrials.gov trial registry to an analysis-ready database of clinical trial results
|
Cepeda, M Soledad
|
|
2013
|
|
2 |
p. 347-348
|
artikel
|
| 104 |
Harry Marks: an appreciation
|
Goodman, Steven N
|
|
2011
|
|
2 |
p. 123-127
|
artikel
|
| 105 |
Healthy Children, Strong Families 2: A randomized controlled trial of a healthy lifestyle intervention for American Indian families designed using community-based approaches
|
Tomayko, Emily J
|
|
2017
|
|
2 |
p. 152-161
|
artikel
|
| 106 |
Identifying treatment effect heterogeneity in clinical trials using subpopulations of events: STEPP
|
Lazar, Ann A
|
|
2016
|
|
2 |
p. 169-179
|
artikel
|
| 107 |
Impact and costs of targeted recruitment of minorities to the National Lung Screening Trial
|
Duda, Catherine
|
|
2011
|
|
2 |
p. 214-223
|
artikel
|
| 108 |
Impact of individual clinical outcomes on trial participants’ perspectives on enrollment in emergency research without consent
|
Whitesides, Louisa W
|
|
2017
|
|
2 |
p. 180-186
|
artikel
|
| 109 |
Impact of stochastically generated heterogeneity in hazard rates on individually randomized vaccine efficacy trials
|
Kahn, Rebecca
|
|
2018
|
|
2 |
p. 207-211
|
artikel
|
| 110 |
Implementation of NIH inclusion guidelines: survey of NIH study section members
|
Taylor, Holly A
|
|
2008
|
|
2 |
p. 140-146
|
artikel
|
| 111 |
Implementing trials of complex interventions in community settings: The USC–Rancho Los Amigos Pressure Ulcer Prevention Study (PUPS)
|
Clark, Florence
|
|
2014
|
|
2 |
p. 218-229
|
artikel
|
| 112 |
IMPROVE trial: A randomized controlled trial of patient-controlled analgesia for sickle cell painful episodes: rationale, design challenges, initial experience, and recommendations for future studies
|
Dampier, Carlton D
|
|
2013
|
|
2 |
p. 319-331
|
artikel
|
| 113 |
Informed patient consent to participation in cluster randomized trials: an empirical exploration of trials in primary care
|
Eldridge, Sandra M
|
|
2005
|
|
2 |
p. 91-98
|
artikel
|
| 114 |
Integrating smoking cessation into mental health care for post-traumatic stress disorder
|
McFall, Miles
|
|
2007
|
|
2 |
p. 178-189
|
artikel
|
| 115 |
Investigational drug labeling variability
|
Duhamel, Amélie
|
|
|
|
2 |
p. 204-213
|
artikel
|
| 116 |
Issues in regulatory guidelines for data monitoring committees
|
DeMets, David
|
|
2004
|
|
2 |
p. 162-169
|
artikel
|
| 117 |
Key cost drivers of pharmaceutical clinical trials in the United States
|
Sertkaya, Aylin
|
|
2016
|
|
2 |
p. 117-126
|
artikel
|
| 118 |
Lack of compliance of European Public Assessment Reports to guidelines for paediatric drug development before the introduction of paediatric investigation plans
|
Piana, Chiara
|
|
2013
|
|
2 |
p. 269-279
|
artikel
|
| 119 |
Landmark clinical trials: a new journal series
|
Goodman, Steven N
|
|
2011
|
|
2 |
p. 128-128
|
artikel
|
| 120 |
Lessons learned from an osteoporosis clinical trial in frail long-term care residents
|
Greenspan, SL
|
|
2012
|
|
2 |
p. 247-256
|
artikel
|
| 121 |
Lessons learned: Infrastructure development and financial management for large, publicly funded, international trials
|
Larson, Gregg S
|
|
2016
|
|
2 |
p. 127-136
|
artikel
|
| 122 |
Letter to the Editor
|
Avins, Andrew
|
|
2011
|
|
2 |
p. 238-238
|
artikel
|
| 123 |
Listen to all the voices: an advocate's perspective on early access to investigational therapies
|
Mayer, Musa
|
|
2006
|
|
2 |
p. 149-153
|
artikel
|
| 124 |
Long-term drug prevention trials
|
Meinert, Curtis L
|
|
2008
|
|
2 |
p. 168-176
|
artikel
|
| 125 |
Maintaining confidentiality of interim data to enhance trial integrity and credibility
|
Fleming, Thomas R
|
|
2008
|
|
2 |
p. 157-167
|
artikel
|
| 126 |
Making the case for completion bonuses in clinical trials
|
Largent, Emily A
|
|
|
|
2 |
p. 176-182
|
artikel
|
| 127 |
Marvin Zelen, 1927–2014
|
Gelber, Richard D
|
|
2015
|
|
2 |
p. 183-184
|
artikel
|
| 128 |
Maximizing power and minimizing treatment failures in clinical trials
|
Rosenberger, William F
|
|
2004
|
|
2 |
p. 141-147
|
artikel
|
| 129 |
Meta-analysis of rare events: an update and sensitivity analysis of cardiovascular events in randomized trials of rosiglitazone
|
Dahabreh, Issa J
|
|
2008
|
|
2 |
p. 116-120
|
artikel
|
| 130 |
Missing not at random models for masked clinical trials with dropouts
|
Kang, Shan
|
|
2015
|
|
2 |
p. 139-148
|
artikel
|
| 131 |
Monitoring futility in a two-by-two factorial design: The SPS3 experience
|
McClure, Leslie A
|
|
2013
|
|
2 |
p. 250-256
|
artikel
|
| 132 |
Motivating the unmotivated for health behavior change: a randomized trial of cessation induction for smokers
|
Carpenter, Matthew J
|
|
2010
|
|
2 |
p. 157-166
|
artikel
|
| 133 |
Multiple-stage screening and mortality in the Multiple Risk Factor Intervention Trial
|
Eberly, Lynn E
|
|
2004
|
|
2 |
p. 148-161
|
artikel
|
| 134 |
National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene trial: Advancing the science of recruitment and breast cancer risk assessment in minority communities
|
McCaskill-Stevens, Worta
|
|
2013
|
|
2 |
p. 280-291
|
artikel
|
| 135 |
Network meta-analysis of randomized clinical trials: Reporting the proper summaries
|
Zhang, Jing
|
|
2014
|
|
2 |
p. 246-262
|
artikel
|
| 136 |
New challenges for 21st century clinical trials
|
Simon, Richard
|
|
2007
|
|
2 |
p. 167-169
|
artikel
|
| 137 |
On-site management of investigational products and drug delivery systems in conformity with Good Clinical Practices (GCPs)
|
Méthot, Julie
|
|
2012
|
|
2 |
p. 265-271
|
artikel
|
| 138 |
Organizational- and employee-level recruitment into a worksite-based weight loss study
|
Linnan, Laura
|
|
2012
|
|
2 |
p. 215-225
|
artikel
|
| 139 |
Outcomes following vaginal prolapse repair and mid urethral sling (OPUS) trial—design and methods
|
Wei, John
|
|
2009
|
|
2 |
p. 162-171
|
artikel
|
| 140 |
Overlap coefficient for assessing the similarity of pharmacokinetic data between ethnically different populations
|
Mizuno, Sachiko
|
|
2005
|
|
2 |
p. 174-181
|
artikel
|
| 141 |
Personal reflections on lessons learned from randomized trials involving newborn infants from 1951 to 1967
|
Silverman, William A.
|
|
2004
|
|
2 |
p. 179-184
|
artikel
|
| 142 |
Planning and core analyses for periodic aggregate safety data reviews
|
Xia, H Amy
|
|
2011
|
|
2 |
p. 175-182
|
artikel
|
| 143 |
PRagmatic trial Of Video Education in Nursing homes: The design and rationale for a pragmatic cluster randomized trial in the nursing home setting
|
Mor, Vincent
|
|
2017
|
|
2 |
p. 140-151
|
artikel
|
| 144 |
Prediction of event times in the REMATCH Trial
|
Ying, Gui-Shuang
|
|
2013
|
|
2 |
p. 197-206
|
artikel
|
| 145 |
Prior distributions for the intracluster correlation coefficient, based on multiple previous estimates, and their application in cluster randomized trials
|
Turner, Rebecca M
|
|
2005
|
|
2 |
p. 108-118
|
artikel
|
| 146 |
Profile-specific survival estimates: Making reports of clinical trials more patient-relevant
|
Julien, Marilyse
|
|
2008
|
|
2 |
p. 107-115
|
artikel
|
| 147 |
Quality assurance of research protocols conducted in the community: The National Institute on Drug Abuse Clinical Trials Network Experience
|
Rosa, Carmen
|
|
2009
|
|
2 |
p. 151-161
|
artikel
|
| 148 |
Randomization inference for balanced cluster-randomized trials
|
Raab, Gillian M
|
|
2005
|
|
2 |
p. 130-140
|
artikel
|
| 149 |
Randomized controlled trial of Nuevo Amanecer: A peer-delivered stress management intervention for Spanish-speaking Latinas with breast cancer
|
Nápoles, Anna M
|
|
2014
|
|
2 |
p. 230-238
|
artikel
|
| 150 |
Randomized trials of alcohol-use interventions with college students and their parents: lessons from the Transitions Project
|
Fernandez, AC
|
|
2011
|
|
2 |
p. 205-213
|
artikel
|
| 151 |
Rationale and design of the SMaRT trial: A randomised, prospective, parallel, non-blinded, one-centre trial to evaluate the use of magnetic resonance imaging in acute setting in patients presenting with suspected scaphoid fracture
|
Rua, Tiago
|
|
2018
|
|
2 |
p. 120-129
|
artikel
|
| 152 |
Recruiting and retaining young adults in a weight gain prevention trial: Lessons learned from the CHOICES study
|
Moe, Stacey G
|
|
2016
|
|
2 |
p. 205-213
|
artikel
|
| 153 |
Recruiting Chinese Americans into cancer screening intervention trials: Strategies and outcomes
|
Wang, Judy Huei-yu
|
|
2014
|
|
2 |
p. 167-177
|
artikel
|
| 154 |
Recruiting community health centers into pragmatic research: Findings from STOP CRC
|
Coronado, Gloria D
|
|
2016
|
|
2 |
p. 214-222
|
artikel
|
| 155 |
Recruitment and retention of participants for an international type 1 diabetes prevention trial: A coordinators’ perspective
|
Franciscus, Margaret
|
|
2014
|
|
2 |
p. 150-158
|
artikel
|
| 156 |
Recruitment of participants to a multiple sclerosis trial: The CombiRx experience
|
Bhanushali, Minal J
|
|
2014
|
|
2 |
p. 159-166
|
artikel
|
| 157 |
Recruitment strategy cost and impact on minority accrual to a breast cancer prevention trial
|
Dew, Alexander
|
|
2013
|
|
2 |
p. 292-299
|
artikel
|
| 158 |
Reducing lost to follow-up in a large clinical trial of prevention of mother-to-child transmission of HIV: The Breastfeeding, Antiretrovirals and Nutrition study experience
|
Sellers, Christopher J
|
|
2015
|
|
2 |
p. 156-165
|
artikel
|
| 159 |
Reducing selection bias in a cluster randomized trial in West African villages
|
Kerry, Sally M
|
|
2005
|
|
2 |
p. 125-129
|
artikel
|
| 160 |
Reflections on Professor Jerome Cornfield’s contributions to the US Food and Drug Administration
|
O’Neill, Robert T
|
|
2013
|
|
2 |
p. 332-336
|
artikel
|
| 161 |
Regional differences in multinational clinical trials: anticipating chance variation
|
Marschner, Ian C
|
|
2010
|
|
2 |
p. 147-156
|
artikel
|
| 162 |
Rejoinder
|
Fleming, Thomas R
|
|
2017
|
|
2 |
p. 126-127
|
artikel
|
| 163 |
Rejoinder
|
Hey, Spencer Phillips
|
|
2015
|
|
2 |
p. 125-127
|
artikel
|
| 164 |
Reminiscences of Jerry Cornfield
|
Lachin, John M
|
|
2013
|
|
2 |
p. 337-339
|
artikel
|
| 165 |
Response
|
Kahn, Susan R
|
|
2015
|
|
2 |
p. 178-178
|
artikel
|
| 166 |
Response to Chappell
|
Vickers, Andrew J
|
|
|
|
2 |
p. 216
|
artikel
|
| 167 |
Response to commentary
|
Proshan, Michael A
|
|
2010
|
|
2 |
p. 120-120
|
artikel
|
| 168 |
Response to Magnus and Wilfond
|
Kim, Scott YH
|
|
2016
|
|
2 |
p. 244-245
|
artikel
|
| 169 |
Restricted mean survival time: Does covariate adjustment improve precision in randomized clinical trials?
|
Karrison, Theodore
|
|
2018
|
|
2 |
p. 178-188
|
artikel
|
| 170 |
Reverse-Bayes analysis of two common misinterpretations of significance tests
|
Held, Leonhard
|
|
2013
|
|
2 |
p. 236-242
|
artikel
|
| 171 |
Review: An examination of effect estimation in factorial and standardly-tailored designs
|
Allore, Heather G
|
|
2008
|
|
2 |
p. 121-130
|
artikel
|
| 172 |
Risks of phase I research with healthy participants: A systematic review
|
Johnson, Rebecca A
|
|
2016
|
|
2 |
p. 149-160
|
artikel
|
| 173 |
Routine data from hospital information systems can support patient recruitment for clinical studies
|
Dugas, Martin
|
|
2010
|
|
2 |
p. 183-189
|
artikel
|
| 174 |
Routine hospital data – is it good enough for trials? An example using England’s Hospital Episode Statistics in the SHIFT trial of Family Therapy vs. Treatment as Usual in adolescents following self-harm
|
Wright-Hughes, Alexandra
|
|
2018
|
|
2 |
p. 197-206
|
artikel
|
| 175 |
Routinely collected data for trialists: The need for continued conversations and solution sharing
|
Lugg-Widger, Fiona V
|
|
|
|
2 |
p. 217-218
|
artikel
|
| 176 |
Sample size under the additive hazards model
|
McDaniel, Lee S
|
|
2016
|
|
2 |
p. 188-198
|
artikel
|
| 177 |
SCT 32nd Annual Meeting, May 15–18, 2011 – Vancouver, British Columbia, Canada
|
|
|
2011
|
|
2 |
p. 239-241
|
artikel
|
| 178 |
Selection criteria and generalizability within the counterfactual framework: explaining the paradox of antidepressant-induced suicidality?
|
Weisberg, Herbert I
|
|
2009
|
|
2 |
p. 109-118
|
artikel
|
| 179 |
Sequential meta-analysis: an efficient decision-making tool
|
van der Tweel, Ingeborg
|
|
2010
|
|
2 |
p. 136-146
|
artikel
|
| 180 |
Should consent forms used in clinical trials be translated into the local dialects? A survey among past participants in rural Ghana
|
Baiden, Frank
|
|
2016
|
|
2 |
p. 234-239
|
artikel
|
| 181 |
Simultaneously optimizing dose and schedule of a new cytotoxic agent
|
Braun, Thomas M.
|
|
2007
|
|
2 |
p. 113-124
|
artikel
|
| 182 |
Society for Clinical Trials
|
|
|
2006
|
|
2 |
p. 165-247
|
artikel
|
| 183 |
Standardized mean differences in individually-randomized and cluster-randomized trials, with applications to meta-analysis
|
White, Ian R
|
|
2005
|
|
2 |
p. 141-151
|
artikel
|
| 184 |
Stopping clinical trials early for benefit: impact on estimation
|
Freidlin, Boris
|
|
2009
|
|
2 |
p. 119-125
|
artikel
|
| 185 |
Stopping trials for efficacy: an almost unbiased view
|
Goodman, Steven N
|
|
2009
|
|
2 |
p. 133-135
|
artikel
|
| 186 |
Strength of evidence for labeled dosing recommendations in renal impairment
|
Gagne, Joshua J
|
|
2017
|
|
2 |
p. 219-221
|
artikel
|
| 187 |
Suspension of accrual in phase II cancer clinical trials
|
Li, Yimei
|
|
2015
|
|
2 |
p. 128-138
|
artikel
|
| 188 |
Targeted therapy in oncology
|
Begg, Colin B.
|
|
2007
|
|
2 |
p. 162-162
|
artikel
|
| 189 |
Target practice: oncology drug development in the era of genomic medicine
|
Schilsky, Richard L.
|
|
2007
|
|
2 |
p. 163-166
|
artikel
|
| 190 |
25 th Annual Meeting of the Society for Clinical Trials Hyatt Regency Hotel, New Orleans, Louisiana Full Conference
|
|
|
2004
|
|
2 |
p. 194-207
|
artikel
|
| 191 |
25 th Annual Meeting of the Society for Clinical Trials Hyatt Regency Hotel, New Orleans, Louisiana Preconference Workshops
|
|
|
2004
|
|
2 |
p. 191-193
|
artikel
|
| 192 |
The calibration of treatment effects from clinical trials to target populations
|
Frangakis, Constantine
|
|
2009
|
|
2 |
p. 136-140
|
artikel
|
| 193 |
The design and conduct of Project RedDE: A cluster-randomized trial to reduce diagnostic errors in pediatric primary care
|
Bundy, David G
|
|
|
|
2 |
p. 154-164
|
artikel
|
| 194 |
The effect of heterogeneity on HIV prevention trials
|
Auvert, Bertran
|
|
2011
|
|
2 |
p. 144-154
|
artikel
|
| 195 |
The feasibility of clinical endpoint trials in HIV infection in the highly active antiretroviral treatment (HAART) era
|
Mocroft, A
|
|
2006
|
|
2 |
p. 119-132
|
artikel
|
| 196 |
The impact of registration of clinical trials units: The UK experience
|
McFadden, Eleanor
|
|
2015
|
|
2 |
p. 166-173
|
artikel
|
| 197 |
The (in)stability of 21st century orthopedic patient contact information and its implications on clinical research: A cross-sectional study
|
London, Daniel A
|
|
2017
|
|
2 |
p. 187-191
|
artikel
|
| 198 |
The net effect of alternative allocation ratios on recruitment time and trial cost
|
Vozdolska, Ralitza
|
|
2009
|
|
2 |
p. 126-132
|
artikel
|
| 199 |
The Positive Emotions after Acute Coronary Events behavioral health intervention: Design, rationale, and preliminary feasibility of a factorial design study
|
Huffman, Jeffery C
|
|
2017
|
|
2 |
p. 128-139
|
artikel
|
| 200 |
The potential for central monitoring techniques to replace on-site monitoring: findings from an international multi-centre clinical trial
|
Bakobaki, Julie M
|
|
2012
|
|
2 |
p. 257-264
|
artikel
|
| 201 |
The 1954 Salk poliomyelitis vaccine field trial
|
Marks, Harry M
|
|
2011
|
|
2 |
p. 224-234
|
artikel
|
| 202 |
The Society for Clinical Trials opposes US legislation to permit marketing of unproven medical therapies for seriously ill patients
|
|
|
2006
|
|
2 |
p. 154-157
|
artikel
|
| 203 |
The Society for Clinical Trials supports United States legislation mandating trials registration
|
Rockhold, Frank
|
|
2005
|
|
2 |
p. 193-193
|
artikel
|
| 204 |
The use and reporting of patient-reported outcomes in phase III breast cancer trials
|
Brim, Remy L
|
|
2013
|
|
2 |
p. 243-249
|
artikel
|
| 205 |
The use of group sequential, information-based sample size re-estimation in the design of the PRIMO study of chronic kidney disease
|
Pritchett, Yili
|
|
2011
|
|
2 |
p. 165-174
|
artikel
|
| 206 |
The use of random effects models to allow for clustering in individually randomized trials
|
Lee, Katherine J
|
|
2005
|
|
2 |
p. 163-173
|
artikel
|
| 207 |
Three-component cure rate model for nonproportional hazards alternative in the design of randomized clinical trials
|
Kim, Haesook Teresa
|
|
2012
|
|
2 |
p. 155-163
|
artikel
|
| 208 |
Translational clinical trials: an entropy-based approach to sample size
|
Piantadosi, Steven
|
|
2005
|
|
2 |
p. 182-192
|
artikel
|
| 209 |
Uptake of novel statistical methods for early-phase clinical studies in the UK public sector
|
Jaki, Thomas
|
|
2013
|
|
2 |
p. 344-346
|
artikel
|
| 210 |
Use of online recruitment strategies in a randomized trial of cancer survivors
|
Juraschek, Stephen P
|
|
2018
|
|
2 |
p. 130-138
|
artikel
|
| 211 |
Using a network-based approach and targeted maximum likelihood estimation to evaluate the effect of adding pre-exposure prophylaxis to an ongoing test-and-treat trial
|
Balzer, Laura
|
|
2017
|
|
2 |
p. 201-210
|
artikel
|
| 212 |
Using factor analysis to confirm the validity of children's self-reported health-related quality of life across different modes of administration
|
Varni, James W
|
|
2009
|
|
2 |
p. 185-195
|
artikel
|
| 213 |
Variance prior specification for a basket trial design using Bayesian hierarchical modeling
|
Cunanan, Kristen M
|
|
|
|
2 |
p. 142-153
|
artikel
|
| 214 |
What can we learn from a decade of database audits? The Duke Clinical Research Institute experience, 1997—2006
|
Rostami, Reza
|
|
2009
|
|
2 |
p. 141-150
|
artikel
|
Tijdschrift beschrijving